In HD and SLE patients, CD19+PLT+ lymphocytes had higher percentages of CD86+ cells and expressed higher levels of BAFFR than the counterpart CD19+PLT- lymphocytes (Figures 3(e) and 3(f)). The gene discussed is CD19; the disease is systemic lupus erythematosus.